信件：幽门螺杆菌随机试验中使用劣质方案的伦理学问题。 - Suppr

Suppr

超能文献

Letter: the ethics of using inferior regimens in H. pylori randomised trials.

作者信息

Graham D Y, Fischbach L A

出版信息

Aliment Pharmacol Ther. 2012 Apr;35(7):852-4; discussion 858. doi: 10.1111/j.1365-2036.2011.04944.x.

DOI:10.1111/j.1365-2036.2011.04944.x

PMID:22404411

Abstract

摘要

相似文献

Letter: the ethics of using inferior regimens in H. pylori randomised trials.信件：幽门螺杆菌随机试验中使用劣质方案的伦理学问题。

Aliment Pharmacol Ther. 2012 Apr;35(7):852-4; discussion 858. doi: 10.1111/j.1365-2036.2011.04944.x.

Letter: the ethics of using inferior regimens in H. pylori randomised trials - invited comment.

Aliment Pharmacol Ther. 2012 Apr;35(7):856-7; discussion 858. doi: 10.1111/j.1365-2036.2011.04985.x.

Letter: the ethics of using inferior regimens in H. pylori randomised trials - invited comment.

Aliment Pharmacol Ther. 2012 Apr;35(7):854-6; discussion 858. doi: 10.1111/j.1365-2036.2011.04951.x.

Letter: curing Helicobacter pylori infection in a clinical setting.

Aliment Pharmacol Ther. 2013 Apr;37(7):757-8. doi: 10.1111/apt.12226.

Commentary: comparators in H. pylori eradication--stating the ethics of statins.

Aliment Pharmacol Ther. 2012 Aug;36(4):400-1. doi: 10.1111/j.1365-2036.2012.05191.x.

Letter: curing Helicobacter pylori infection in a clinical setting--authors' reply.

Aliment Pharmacol Ther. 2013 Apr;37(7):758-9. doi: 10.1111/apt.12250.

Commentary: comparators in H. pylori eradication -- stating the ethics of statins; author's reply.

Aliment Pharmacol Ther. 2012 Aug;36(4):401. doi: 10.1111/j.1365-2036.2012.05193.x.

Commentary: Helicobacter pylori eradication in Western Australia.

Aliment Pharmacol Ther. 2013 Jan;37(1):158; discussion 159. doi: 10.1111/apt.12129.

Commentary: simvastatin as the key to improving H. pylori eradication rates?

Aliment Pharmacol Ther. 2012 Sep;36(5):493; author reply 494. doi: 10.1111/j.1365-2036.2012.05195.x.

Concomitant, sequential, and hybrid therapy for Helicobacter pylori: which one is the correct answer?幽门螺杆菌的联合、序贯和混合疗法：哪一种是正确答案？

Clin Res Hepatol Gastroenterol. 2013 Dec;37(6):e125-6. doi: 10.1016/j.clinre.2013.07.007. Epub 2013 Aug 24.

引用本文的文献

Sequential versus Standard Triple Therapy for First-Line Eradication: An Update.一线根除治疗的序贯疗法与标准三联疗法：最新进展

Antibiotics (Basel). 2024 Jan 30;13(2):136. doi: 10.3390/antibiotics13020136.

Empiric therapy-10-day concomitant, bismuth quadruple or 14-day triple therapy: none is best.经验性治疗——10天联合铋剂四联疗法或14天三联疗法：没有一种是最佳的。

Transl Cancer Res. 2016 Dec;5(Suppl 7):S1476-S1478. doi: 10.21037/tcr.2016.12.39.

Sequential versus standard triple first-line therapy for Helicobacter pylori eradication.用于根除幽门螺杆菌的序贯疗法与标准三联一线疗法对比

Cochrane Database Syst Rev. 2016 Jun 28;2016(6):CD009034. doi: 10.1002/14651858.CD009034.pub2.

Sequential Therapy versus Triple Therapy for the First Line Treatment of Helicobacter pylori in Korea: A Nationwide Randomized Trial.韩国幽门螺杆菌一线治疗的序贯疗法与三联疗法对比：一项全国性随机试验

Gut Liver. 2016 Jul 15;10(4):556-61. doi: 10.5009/gnl15470.

Vonoprazan Helicobacter pylori eradication therapy: ethical and interpretation issues.沃克帕唑根除幽门螺杆菌治疗：伦理与解读问题。

Gut. 2017 Feb;66(2):384-386. doi: 10.1136/gutjnl-2016-311796. Epub 2016 Apr 7.

Rational Helicobacter pylori therapy: evidence-based medicine rather than medicine-based evidence.合理的幽门螺杆菌治疗：基于证据的医学，而不是基于证据的医学。

Clin Gastroenterol Hepatol. 2014 Feb;12(2):177-86.e3; Discussion e12-3. doi: 10.1016/j.cgh.2013.05.028. Epub 2013 Jun 8.

Is concomitant quadruple therapy for Helicobacter pylori eradication really needed for Japanese patients?日本患者真的需要采用联合四联疗法来根除幽门螺杆菌吗？

World J Gastrointest Pharmacol Ther. 2012 Dec 6;3(6):103-4. doi: 10.4292/wjgpt.v3.i6.103.

Which Therapy for Helicobacter pylori Infection?幽门螺杆菌感染该用哪种治疗方法？

Gastroenterology. 2012 Jul;143(1):10-2. doi: 10.1053/j.gastro.2012.05.012. Epub 2012 May 18.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验